Loading...

VERV VERVE THERAPEUTICS INC Management Changes 8-K Filing

VRV

VRV

VERVE THERAPEUTICS INC

(VERV)

2024 8-K

Show Summary

Show Summary

Merger of Equals

Financial Statements

Clinical Trial Update

Financial Results

Financial Results

Financial Results Announcement

Board Expansion and New Dir...

Update on Advisory Vote on ...

Annual Meeting of Stockholders

Appointment of Chief Scient...

Financial Results Announcement

Clinical Trial Pause

Financial Results Announcement

Underwriting Agreement

Interim Data Presentation

Financial Results Announcement

FDA Clearance for Clinical ...

Financial Results Announcement

Annual Meeting Results

Research Collaboration Agre...

Financial Results Announcement

Financial Results Announcement

Bylaws Amendment

External Links:

Verve Therapeutics appoints Troy Lister as Chief Scientific Officer, succeeding Andrew Bellinger who will resign, with details of separation agreement and compensation.

AI Assistant

VERVE THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.